Literature DB >> 34856634

Hypersensitivity myocarditis and COVID-19 vaccines.

Nicholas G Kounis1, Virginia Mplani2, Ioanna Koniari3, Dimitrios Velissaris4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34856634     DOI： 10.33963/KP.a2021.0166

Source DB:  PubMed          Journal:  Kardiol Pol        ISSN： 0022-9032            Impact factor:   3.108


× No keyword cloud information.
  5 in total

1.  Reader comments.

Authors:  Nicholas G Kounis; Virginia Mplani; Ioanna Koniari; Panagiotis Plotas
Journal:  Proc (Bayl Univ Med Cent)       Date:  2022-04-29

Review 2.  Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.

Authors:  Jennifer Pillay; Lindsay Gaudet; Aireen Wingert; Liza Bialy; Andrew S Mackie; D Ian Paterson; Lisa Hartling
Journal:  BMJ       Date:  2022-07-13

3.  Network pharmacology-based predictions of active components and pharmacological mechanisms of Artemisia annua L. for the treatment of the novel Corona virus disease 2019 (COVID-19).

Authors:  Yexiao Tang; Xiaobo Li; Yueming Yuan; Hongying Zhang; Yuanyuan Zou; Zhiyong Xu; Qin Xu; Jianping Song; Changsheng Deng; Qi Wang
Journal:  BMC Complement Med Ther       Date:  2022-03-03

4.  Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis.

Authors:  Ryan Ruiyang Ling; Kollengode Ramanathan; Felicia Liying Tan; Bee Choo Tai; Jyoti Somani; Dale Fisher; Graeme MacLaren
Journal:  Lancet Respir Med       Date:  2022-04-11       Impact factor: 102.642

5.  Network pharmacology and molecular docking-based investigations of Kochiae Fructus's active phytomolecules, molecular targets, and pathways in treating COVID-19.

Authors:  Shakeel Ahmad Khan; Terence Kin Wah Lee
Journal:  Front Microbiol       Date:  2022-08-05       Impact factor: 6.064
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.